| Description | The enzyme is useful for the determination of α-amylase and inorganic phosphate in clinical analysis.PROPERTIESMolecular weight: ca. 34 kDa (gel filtration)Structure: monomer of ca. 25 kDa (SDS-PAGE)Michaelis constant: 2.3×10^−4 M (β-d-glucose-1-phosphate)pH Optimum: ca. 7.0 (The enzyme is useful for the determination of α-amylase and inorganic phosphate in clinical analysis.PROPERTIESMolecular weight: ca. 34 kDa (gel filtration)Structure: monomer of ca. 25 kDa (SDS-PAGE)Michaelis constant: 2.3×10^−4 M (β-d-glucose-1-phosphate)pH Optimum: ca. 7.0 (Fig. 1)pH Stability: 5.0–9.5 (Fig. 2)Optimum temperature: 40°C (Fig. 3)Thermal stability: below 45°C (Fig. 4)Stability (liquid form): stable at 37°C for at least one week (Fig. 5)Stability (powder form): stable at 30°C for at lest one month (Fig. 6)Activators: Mg2+, Mn2+, Co2+, Ni2+Inhibitors: Hg2+, Zn2+, Cu2+, Cd2+STABILIZERS: lactose, EDTAASSAY PROCEDURE PrincipleThe appearance of NADPH is measured spectrophotometrically at 340 nm.ReagentsA. HEPES–NaOH buffer, 0.3 M; pH 7.0, containing 40 mM KCl, 4 mM MgCl2 and 1.6% (w/v) Triton X-100: dissolve 7.15 g of HEPES, 298 mg of KCl, 81.3 mg of MgCl2·6H2O and 1.6 g of Triton X-100 in 75 ml of distilled water, adjust to pH 7.0 with 4 N NaOH and dilute with distilled water to 100 ml.B. d-Glucose-1,6-bisphosphate (G-1,6-P2) solution, 3.0 mM : 60.7 mg of G-1,6-P2 cyclohexylammonium·4H2O/ 25 ml of distilled water.C. NADP+ solution, 12 mM: 230 mg of NADP+·Na/25 ml of distilled water.D. β-d-Glucose-1-phosphate (β-G-1-P) solution, 22 mM:167 mg of β-G-1-P disodium salt/25 ml of distilled water.E. Glucose-6-phosphate dehydrogenase (G6PDH) solution: 1750 U/ml.F. Enzyme dilution buffer: mix 10 mM KH2PO4 solution and 10 mM K2HPO4 solution to make a pH 7.0 solution.Sample: dissolve the lyophilized enzyme to a volume activity of 1.0–3.0 U/ml with ice-cold enzyme dilution buffer (Reagent F) immediately before measurement. Procedure1. Pipette the following reagents into a cuvette (light path: 1 cm).1.5 ml HEPES–NaOH buffer (Reagent A)0.3 ml G-1,6-P2 solution (Reagent B)0.3 ml NADP+ solution (Reagent C)0.3 ml β-G-1-P solution (Reagent D) 0.02 ml G6PDH solution (Reagent E)0.6 ml Distilled water2. Equilibrate at 37°C for about 5 min.3. Add 0.03 ml of sample and mix.4. Record the increase of absorbance at 340 nm in a spectrophotometer thermostated at 37°C, and calculate the ∆Aper min using the linear portion of the curve (∆AS).The blank solution is prepared by adding enzyme dilution buffer (Reagent F) instead of sample (∆A0).CalculationActivity can be calculated by using the following formula:6.2: Millimolar extinction coefficient of NADPH at 340 nm (cm2/µmol)df: Dilution factorC: Content of β-phosphoglucomutase preparation in sample (mg/ml)APPLICATIONSThe enzyme is useful for the determination of α-amylase and inorganic phosphate in clinical analysis.EXPERIMENTAL DATA... Read More | Inquire | H-7 dihydrochloride blocks human immunodeficiency virus (HIV-1) replication in MOLT-4 (clone No. 8) cell line. It increases the secretion of interleukin 1β (IL-1β).Application：H-7 dihydrochloride has been used to study H-7-induced inhibition of contractility in rat embryo H-7 dihydrochloride blocks human immunodeficiency virus (HIV-1) replication in MOLT-4 (clone No. 8) cell line. It increases the secretion of interleukin 1β (IL-1β).Application：H-7 dihydrochloride has been used to study H-7-induced inhibition of contractility in rat embryo fibroblasts (REF52) cells and acts as a kinase inhibitor... Read More | Purity：>95%(SDS-PAGE) Function：Cooperates with MD-2 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Up-regulates cell surface Purity：>95%(SDS-PAGE) Function：Cooperates with MD-2 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Up-regulates cell surface molecules, including adhesion molecules.Background：CD14 is a 55 kDa cell surface glycoprotein that is preferentially expressed on monocytes/macrophages. The human CD14 cDNA encodes a 375 amino acid (aa) residue precursor protein with a 19 aa signal peptide and a C-terminal hydrophobic region characteristic for glycosylphosphatidyinositol (GPI)-anchored proteins. Human CD14 has four potential N-linked glycosylation sites and also bears O-linked carbohydrates. The amino acid sequence of human CD14 is approximately 65% identical with the mouse, rat, rabbit, and bovine proteins. CD14 is a pattern recognition receptor that binds lipopolysaccharides (LPS) and a variety of ligands derived from different microbial sources. The binding of CD14 with LPS is catalyzed by LPS-binding protein (LBP). The toll-like-receptors have also been implicated in the transduction of CD14-LPS signals. Similar to other GPI-anchored proteins, soluble CD14 can be released from the cell surface by phosphatidyinositol-specific phospholipase C. Soluble CD14 has been detected in serum and body fluids. High concentrations of soluble CD14 have been shown to inhibit LPS-mediated responses. However, soluble CD14 can also potentiate LPS response in cells that do not express cell surface CD14... Read More | Purity> 97 % by SDS-PAGE and HPLC analyses.Additional sequence informationMature protein.FunctionPromotes neurite outgrowth and especially branching of neuritic processes in primary hippocampal and cortical cells |